Charles Schwab Investment Management Inc. Boosts Stock Position in Mettler-Toledo International, Inc. (NYSE:MTD)

Charles Schwab Investment Management Inc. grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 3.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 146,592 shares of the medical instruments supplier's stock after purchasing an additional 5,329 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.70% of Mettler-Toledo International worth $173,112,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Greenleaf Trust boosted its position in Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the last quarter. Albion Financial Group UT boosted its position in Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares during the last quarter. TD Private Client Wealth LLC boosted its position in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after purchasing an additional 11 shares during the last quarter. Finally, Congress Asset Management Co. boosted its position in Mettler-Toledo International by 1.8% in the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock worth $788,000 after purchasing an additional 12 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the topic of several recent research reports. Robert W. Baird raised their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Evercore ISI decreased their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their target price for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $1,288.89.

Mettler-Toledo International Stock Performance

NYSE:MTD traded down $8.90 during trading hours on Thursday, reaching $1,315.16. The stock had a trading volume of 71,143 shares, compared to its average volume of 175,216. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The company has a 50 day moving average price of $1,210.00 and a two-hundred day moving average price of $1,190.94. The stock has a market capitalization of $27.09 billion, a PE ratio of 33.30, a PEG ratio of 3.88 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the previous year, the company posted $9.65 EPS. The company's revenue was up 3.9% compared to the same quarter last year. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares of the company's stock, valued at approximately $6,389,588.55. The trade was a 5.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director directly owned 120 shares in the company, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.